Deficiency of KMT2E‐AS1 protected against PAH in mice, while its overexpression exacerbated PH, highlighting the KMT2E‐AS1/KMT2E axis as a crucial target in PAH management [334, 335]. Here, KMT2E is linked to pulmonary arterial hypertension.